Chandler R, Montenegro N, Llorach C, Aguirre LN, et al. Immunogenicity, Reactogenicity, and Safety of AS01E-adjuvanted RSV Prefusion F Protein-based Candidate Vaccine (RSVPreF3 OA) When Co-administered With a Seasonal Quadrivalent Influenza Vaccine in Older Adults: Results of a Phase 3, Open-Label, Randomi Clin Infect Dis 2024 Jan 8:ciad786. doi: 10.1093.
PMID: 38189778